Hip effusion/synovitis influences results after multiple drilling core decompression for bone marrow edema syndrome

Hua-Zhang Xiong1, Yan-Li Peng1, Yu-Hong Deng1

  • 1Department of Orthopedic Surgery, Affiliated Hospital of Zunyi Medical University, 149# Dalian Road, Zunyi, Guizhou Province, 563003, People's Republic of China.

BMC Surgery
|June 3, 2023
PubMed

Insights

Hip effusion/synovitis impacts outcomes for bone marrow edema syndrome of the hip (BMESH) treated with multiple drilling core decompression (MDCD). Addressing effusion/synovitis improves pain relief and healing time, offering a safe, effective treatment.

Area of Science:

  • Orthopedic Surgery
  • Regenerative Medicine
  • Musculoskeletal Imaging

Background:

  • Bone marrow edema syndrome of the hip (BMESH) is a painful condition.
  • The impact of hip effusion/synovitis on the efficacy of multiple drilling core decompression (MDCD) for BMESH remains unclear.
  • Assessing hip effusion/synovitis and its correlation with MDCD outcomes is crucial for treatment optimization.

Purpose of the Study:

  • To evaluate the influence of hip effusion/synovitis on the therapeutic results of MDCD in BMESH patients.
  • To determine if arthroscopic management of hip effusion/synovitis enhances clinical outcomes post-MDCD.
  • To investigate the safety and efficacy of combined arthroscopic treatment for BMESH with effusion/synovitis.

Main Methods:

  • Retrospective review of arthroscopic-assisted MDCD for BMESH with hip effusion/synovitis (2016-2019).
  • Follow-up of seven patients (9 hips) at multiple intervals (1-24 months) post-surgery.
  • Assessment of pain and function using VAS, HHS, HOS-ADL, iHOT-12, and ROM, comparing pre- and post-operative data.

Main Results:

  • Immediate pain relief at rest and return to pre-operative activity levels by 3 months post-surgery.
  • Significant improvements in VAS, HHS, HOS-ADL, iHOT-12, and ROM at 1 month compared to pre-operative values (P < 0.05).
  • Complete resolution of bone marrow edema on MRI by 3 months; no ROM limitations at final follow-up. Concomitant intra-articular pathologies identified and treated in some cases.

Conclusions:

  • Hip effusion/synovitis significantly affects clinical outcomes following MDCD for BMESH.
  • Arthroscopic intervention for hip effusion/synovitis shortens pain relief and edema resolution times.
  • This approach is safe, allows simultaneous diagnosis and treatment of intra-articular pathologies, and leads to fewer complications.
Abstract